Kolexia
Guglielmetti Lorenzo Maladies infectieuses
Guglielmetti Lorenzo
Maladies infectieuses
Hôpital Pitie Salpetriere
Paris, France
102 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tuberculose Tuberculose multirésistante Tuberculose ultrarésistante aux médicaments Tuberculose pulmonaire Maladies pulmonaires Infections à mycobactéries non tuberculeuses Infections bactériennes COVID-19 Infections à Mycobacterium

Collaborateurs

Voir plus
Veziris Nicolas
Veziris Nicolas
Hôpital Saint-Antoine, Paris, France
Robert Jerome
Robert Jerome
Hôpital Pitie Salpetriere, Paris, France
Frechet-Jachym Mathilde
Frechet-Jachym Mathilde
Centre Hospitalier De Bligny, Briis-sous-Forges, France
Le Du Damien
Le Du Damien
Centre Hospitalier De Bligny, Briis-sous-Forges, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis.
Thorax   22 décembre 2023
Standards for clinical trials for treating TB.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease   15 décembre 2023
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Trials   30 novembre 2023
endTB: Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Essai Clinique (Médecins Sans Frontières, France)   21 août 2023
Recent advances in the treatment of tuberculosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   22 juillet 2023
endTB-Q: Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
Essai Clinique (Médecins Sans Frontières, France)   20 juillet 2023
Optimal management of drug-resistant tuberculosis: Can India lead the way?
The Indian journal of medical research   22 mai 2023
Relative cost of multidrug-resistant TB medicines in Europe.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease   08 mai 2023
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease   11 avril 2023
Tailored TPT for drug-resistant TB - promoting equity and access to optimal care.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease   02 mars 2023